Prevention and treatment of rethrombosis after liver transplantation with an implantable pump of the portal vein

Zhengrong Shi, Lunan Yan, Jichun Zhao, Bo Li, Tianfu Wen, Mingqing Xu, Wentao Wang, Zheyu Chen, Jiaying Yang – 5 March 2010 – Implantable pumps have been used to prevent deep vein thrombosis and other diseases. In this article, we report for the first time the prevention and treatment of rethrombosis of the portal vein in liver transplantation with an implantable pump of the portal vein.

Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit

Maartje A. J. van den Broek, Steven W. M. Olde Damink, Bjorn Winkens, Christoph E. Broelsch, Massimo Malagó, Andreas Paul, Fuat H. Saner – 5 March 2010 – Clinically significant infections (CSIs) are life‐threatening but difficult to diagnose after liver transplantation (LTx). This study investigates the value of procalcitonin (PCT) in addition to c‐reactive protein (CRP) and the leukocyte count (LC) as a prognostic marker for CSIs in LTx recipients. The clinical course of 135 LTx recipients was prospectively studied.

Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before

Yasuhiro Ogura, Tomohide Hori, Walid M. El Moghazy, Atsushi Yoshizawa, Fumitaka Oike, Akira Mori, Toshimi Kaido, Yasutsugu Takada, Shinji Uemoto – 1 March 2010 – To prevent small‐for‐size syndrome in adult‐to‐adult living donor liver transplantation (A‐LDLT), larger grafts (ie, right lobe grafts) have been selected in many transplant centers. However, some centers are investigating the benefits of portal pressure modulation. Five hundred sixty‐six A‐LDLT procedures using right or left lobe grafts were performed between 1998 and 2008.

Comparison of calibrated and uncalibrated arterial pressure–based cardiac output monitors during orthotopic liver transplantation

Vladimir Krejci, Andrea Vannucci, Alhan Abbas, William Chapman, Ivan M. Kangrga – 1 March 2010 – Arterial pressure–based cardiac output monitors (APCOs) are increasingly used as alternatives to thermodilution. Validation of these evolving technologies in high‐risk surgery is still ongoing. In liver transplantation, FloTrac‐Vigileo (Edwards Lifesciences) has limited correlation with thermodilution, whereas LiDCO Plus (LiDCO Ltd.) has not been tested intraoperatively.

Subscribe to